flashplate microplate (Revvity)
Revvity is a verified supplier 
Revvity manufactures this product 
90
Structured Review
Revvity
flashplate microplate
Flashplate Microplate, supplied by Revvity, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microplate+basic+flashplates/FlashPlate+Basic+Microplate%2C+50+Plates/10__1016_slash_j__ejmech__2017__04__017-200-17-19
Average 90 stars, based on 4 article reviews
Flashplate Microplate, supplied by Revvity, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microplate+basic+flashplates/FlashPlate+Basic+Microplate%2C+50+Plates/10__1016_slash_j__ejmech__2017__04__017-200-17-19
Average 90 stars, based on 4 article reviews
flashplate microplate - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Incubation:Article Title: Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity† Article Snippet: Bruce G. Szczepankiewicz,* Christi Kosogof, Lissa T. J. Nelson, Gang Liu, Bo Liu, Hongyu Zhao, Michael D. Serby, Zhili Xin, Mei Liu, Rebecca J. Gum, Deanna L. Haasch, Sanyi Wang, Jill E. Clampit, Eric F. Johnson, Thomas H. Lubben, Michael A. Stashko, Edward T. Olejniczak, Chaohong Sun, Sarah A. Dorwin, Kristi Haskins, Cele Abad-Zapatero, Elizabeth H. Fry, Charles W. Hutchins, Hing L. Sham, Cristina M. Rondinone,‡ and James M. Trevillyan Activity Assay:Article Title: A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models Article Snippet: The importance of PRMT5 in tumorigenesis is highlighted in several reports.. PRMT5 is upregulated in several human malignancies, including lymphomas1–3, lung cancer4, breast cancer5 and colorectal cancer6.. In addition, PRMT5 is reported to have a role in MCL, as evidenced not only by upregulation of PRMT5 in patient samples, but also by antiproliferative effects observed after PRMT5 knockdown in MCL cell lines1–3,7. |